中西医结合治疗晚期肝癌验案1例报告  

Integrated Traditional Chinese and Western Medicine for the Treatment of Advanced Intrahepatic Cholangiocarcinoma:One Case Report

作　　者：石彧 王志祥[1] 孙丕云 文玲波 李蓉 斯韬[1] 阮雯琪 SHI Yu;WANG Zhi-xiang;SUN Pi-yun;WEN Ling-bo;LI Rong;SI Tao;RUAN Wen-qi(Department of Oncology,the Third Affiliated Hospital of Guangxi University of Chinese Medicine,Liuzhou 545001 Guangxi,China)

机构地区：[1]广西中医药大学附属第三医院肿瘤科,广西柳州545001

出　　处：《中医肿瘤学杂志》2023年第6期64-68,共5页Journal of Oncology in Chinese Medicine

基　　金：国家自然科学基金面上资助项目(编号:8206856)。

摘　　要：由于肝癌起病隐匿,多数患者确诊时已经是中晚期,失去了根治机会,若不经有效治疗,自然生存期仅3个月~4个月。中医治疗晚期肝癌有其独特优势,本文介绍中西医结合治疗晚期肝癌1例,分阶段运用经验方和经方结合,联合口服索拉非尼、仑伐替尼加局部放疗,总体来说,患者病情稳定,生活质量良好。截至2023年9月,患者总生存期达4年。Due to the hidden onset of liver cancer,most patients are diagnosed in the advanced stage and lose the opportunity for radical treatment.Without effective treatment,the natural survival period is only 3 to 4 months.Traditional Chinese medicine(TCM)has its unique advantages in the treatment of advanced liver cancer.This article introduces a case of advanced liver cancer treated with the integration of TCM and western medicine.The patient was treated with experience and classic prescription in different stages,combined with sorafenib,lenvatinib,and local radiotherapy.Generally speaking,the patient was in stable condition and her quality of life was good.Up to September 2023,the overall survival of this patient reached 4 years.

关 键 词：肝癌 中医药 中西医结合治疗 治疗策略 

分 类 号：R273[医药卫生—中西医结合] R735.7[医药卫生—中医肿瘤科]